Justin Taylor, Assistant Professor at UM Sylvester Comprehensive Cancer Center and Principle Investigator at the Taylor Lab, made the following post on Twitter:
“Excited to see this paper in print Leukemia Journal! Many preclinical studies using RBM39 molecular glue degraders e.g indisulam. We show that E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies.
Great collaboration between Memorial Sloan Kettering Cancer Center and Sylvester Comprehensive Cancer Center! Led by twitter-less Drs. Jan Bewersdorf and Eytan Stein, Abdel Wahab Lab, Lu Lab, Namrata Chandhok, Justin Watts and many others. Access to the full text here.”
Source: Justin Taylor/Twitter